Caricamento pagina

Stevanato Group Hosts His First Capital Markets Day

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Stevanato Group Hosts His First Capital Markets Day</span>

Throwback to our First Capital Markets Day

Nearly two years ago an important milestone marked Stevanato Group’s journey: our listing on the New York Stock Exchange and last September 26th,  we were back in New York proud and excited for our first Capital Markets Day.

As a listed Company, this was a cornerstone occasion to provide our investors and analysts with the opportunity to meet our management and learn more about our business and future plans.

Preparation, accountability, humility, passion, proactivity, and ambition - these are just some of the key attitudes and behaviors characterizing us and the path we are undergoing.

Our goal is to be your global partner of choice, positioned to meet increasing demand for end-to-end solutions from drug development through life-cycle management, shaping together the pharma of the future!
Stevanato Group
Stevanato Group

Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.

Other news

products

Digital Holographic Microscopy (DHM®): A New Method to Characterize Silicone Coatings for Safer, Higher-Performance Drugs

1 minute read
products

ITC Syringe with Enlarged Inner Cone (EIC): Enhancing Compatibility for Intravenous (IV) Drug Delivery

1 minute read
products

The Superior Mechanical Resistance of Nexa® Vials for Improved Efficiency and Safety

1 minute read
Return to news